Taylor Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Hold
1,485
0.21% 80
2026
Q1
$323K Sell
1,485
-66
-4% -$14.6K 0.2% 82
2025
Q4
$354K Hold
1,551
0.21% 81
2025
Q3
$359K Hold
1,551
0.21% 79
2025
Q2
$288K Hold
1,551
0.18% 82
2025
Q1
$325K Buy
1,551
+152
+11% +$29.5K 0.23% 75
2024
Q4
$249K Hold
1,399
0.17% 83
2024
Q3
$276K Hold
1,399
0.19% 82
2024
Q2
$240K Sell
1,399
-1
-0.1% -$166 0.18% 79
2024
Q1
$255K Sell
1,400
-90
-6% -$15.5K 0.19% 77
2023
Q4
$231K Buy
+1,490
New +$217K 0.19% 82

Other funds holding ABBV

Taylor Financial Group's ABBV Position: Q2 2026 in Review

Taylor Financial Group held its AbbVie (ABBV) position steady in Q2 2026 at 1,485 shares worth $374K. The position accounts for 0.21% of the portfolio, ranked #80.

Taylor Financial Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Taylor Financial Group held 1,485 shares of AbbVie worth $374K as of Q2 2026.
  • Taylor Financial Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.21% of Taylor Financial Group's portfolio in Q2 2026, its #80 holding.
  • Taylor Financial Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Taylor Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.